NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
11 hedge funds and large institutions have $229K invested in NexImmune, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 19 closing their positions.
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
63% less funds holding
Funds holding: 30 → 11 (-19)
75% less capital invested
Capital invested by funds: $921K → $229K (-$692K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.21K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.46K |
| 3 |
Morgan Stanley
New York
|
+$54 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AO
Allen Operations
New York
|
-$134K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$67.3K |
| 3 |
First Manhattan
New York
|
-$31.3K |
| 4 |
MCM
M28 Capital Management
Stamford,
Connecticut
|
-$28K |
| 5 |
CG
Caprock Group
Boise,
Idaho
|
-$21.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BBA
26
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
| – | -$3.23K | -690 | Closed |
|
27
Northern Trust
Chicago,
Illinois
| – | -$2.66K | -507 | Closed |
|
28
Two Sigma Investments
New York
| – | -$2.12K | -403 | Closed |
|
|
SSWM
29
Smith Salley Wealth Management
Greensboro,
North Carolina
| – | -$2.1K | -400 | Closed |
|
30
Osaic Holdings
Scottsdale,
Arizona
| – | -$210 | -40 | Closed |
|
31
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$1 | – | – |
|
NEXI Hedge Fund Activity: Q4 2023 in Review
11 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q4 2023, worth a combined $229K — down 75% from $921K a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of NEXI and 0 opened new positions — a net loss of 19 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $5.21K. The largest seller was Allen Operations, exiting entirely with an estimated $134K sold.
- 11 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q4 2023, down from 30 in Q3 2023.
- Funds reported $229K of NexImmune, Inc. Common Stock stock for Q4 2023, down 75% quarter-over-quarter.
- 0 funds opened new NexImmune, Inc. Common Stock positions in Q4 2023 and 19 closed out, a net change of -19 holders.
- The largest NexImmune, Inc. Common Stock buyer in Q4 2023 was Tower Research Capital (TRC), an estimated $5.21K added.
- The largest NexImmune, Inc. Common Stock seller in Q4 2023 was Allen Operations, an estimated $134K sold.
Based on aggregated 13F filings for Q4 2023.